📌 Key Takeaways
- South Korea’s National Assembly passed the Cosmetics Industry Promotion and Support Act on August 20, 2026 —
the country’s first standalone law dedicated to growing its beauty industry. - Korean cosmetics exports reached a record US$11.4 billion in 2025,
making cosmetics the single largest SME export category in the country. - The law introduces an “Innovative Cosmetics Company” certification system,
mandates 5-year national development plans, and explicitly integrates AI and data technology. - Quality control concerns persist alongside rapid growth —
the government is running promotion and safety oversight as parallel tracks.
K-beauty is no longer just a trend.
On August 20, 2026, South Korea’s National Assembly voted to make it a matter of national policy.
The newly passed Cosmetics Industry Promotion and Support Act is the first law in Korean history
dedicated solely to developing the cosmetics industry as a strategic sector —
separate from existing safety and quality regulations.
(Source: Personal Care Insights / CNS Media, August 24, 2026)
The backdrop is striking: Korean cosmetics exports hit a record US$11.4 billion in 2025,
positioning the country as a top-two global exporter.
But rapid growth has also raised questions about quality control —
a tension this new law attempts to address through parallel legislative tracks.
INDEX
What the Cosmetics Industry Promotion Act Actually Does
Until now, Korea’s cosmetics sector was governed primarily by the Cosmetics Act,
which focuses on safety and quality management.
What was missing was a dedicated legal framework for growing the industry.
The new law fills that gap.
covering R&D, raw materials, packaging, distribution, and overseas expansion.
(Source: Korea Ministry of Health and Welfare official announcement)
granting preferential access to government and local R&D support programs.
SMEs are explicitly prioritized under this framework.
(Specific criteria to be finalized in implementing regulations)
A joint public-private “Cosmetics Industry Promotion Support Committee”
will coordinate policy implementation.
within the cosmetics industry —
legally positioning K-beauty as a technology-driven export sector.
(Source: Korea Ministry of Health and Welfare)
Alongside the Cosmetics Industry Promotion Act, the National Assembly also passed
an amendment to the Medical Devices Act on August 20, 2026.
The amendment strengthens monitoring of online medical device advertising
and requires platform operators to take corrective action against non-compliant listings.
In short: industry promotion and advertising oversight are advancing simultaneously.
The law takes effect one year after official promulgation,
following approval by the State Council (Cabinet) and formal publication.
Implementing regulations — including certification criteria — are still being drafted as of August 2026.
Note: The Cosmetics Industry Promotion Act (industry development) and the existing Cosmetics Act (safety & quality) are two separate laws.
K-Beauty Exports Hit $11.4 Billion — How Did Korea Get Here?
Korean cosmetics exports reached US$11.4 billion in 2025 — a record high,
confirmed by the Korea Ministry of Health and Welfare.
Cosmetics now represent the largest single export category among Korean SMEs.
The Ministry of Health and Welfare has stated a goal of reaching global #1 under the new law.
Specific recall figures from MFDS primary sources require independent verification.
Source: Personal Care Insights (CNS Media), August 24, 2026 / Korea Ministry of Health and Welfare / MFDS
Growth vs. Quality Control: The Central Tension
Rapid export growth has not come without friction.
Secondary reporting has flagged an increase in cosmetics recalls,
though NERO was unable to independently verify specific recall figures
from MFDS primary sources at the time of publication.
will advance in parallel with industry promotion —
not as a trade-off, but as a dual mandate.
(Independent verification of primary sources recommended)
there is a risk that quality management infrastructure
may not scale as quickly as production and distribution.
The law’s effectiveness will ultimately depend on how implementing regulations are enforced.
Korea’s legislative response is structurally notable:
rather than combining promotion and safety in a single law,
the government has deliberately kept them separate but parallel —
the new Promotion Act alongside the existing Cosmetics Act.
Whether this dual-track design delivers in practice remains to be seen.
What This Means for Global Beauty and Aesthetic Medicine Markets
This law does not apply outside Korea.
It is also important to note that it covers cosmetics —
not aesthetic medical devices, injectable treatments, or pharmaceuticals.
That said, the ripple effects on adjacent markets are worth tracking.
HIFU, RF, laser, and skin booster technologies included.
With state-backed R&D and export support, Korean products
are likely to become even more competitive in global markets.
Korea signals intent to export not just products
but skincare diagnostic platforms and personalized beauty technology.
This creates both competitive pressure and partnership opportunities
for beauty markets worldwide.
consumers and clinics globally should pay closer attention
to manufacturer transparency, ingredient sourcing, and recall history
when selecting Korean-origin products.
“Made in Korea” is neither a guarantee of quality nor a reason for concern.
The right question is: “Has this product or device received regulatory approval
in the country where it is being used?”
• Can the clinic confirm the regulatory classification and approval number
of any device used in your treatment?
• Has the skin booster or injectable been approved by the relevant national authority
(e.g., FDA, EMA, PMDA)?
• “Widely used in Korea” is not a substitute for regulatory approval elsewhere.
What matters here is that Korea has transformed K-beauty
from a cultural trend into a legal institution.
This isn’t just about individual products —
it’s about designing an entire ecosystem:
raw materials, packaging, distribution, and global expansion,
all architected at the national level.
The question for other markets is whether they can respond
with equivalent institutional seriousness —
or whether they’ll keep consuming Korean innovation
without a strategic framework of their own.
What NERO finds most structurally significant
is Korea’s deliberate choice to keep promotion and safety
as separate laws rather than combining them.
“Growing an industry” and “protecting consumers”
are treated as distinct mandates — each with its own legal architecture.
That design philosophy raises a legitimate question
for regulatory frameworks everywhere:
are your growth incentives and your safety guardrails
actually running in parallel, or quietly trading off against each other?
Summary
- South Korea’s National Assembly passed the Cosmetics Industry Promotion and Support Act on August 20, 2026 —
the country’s first standalone industry development law for cosmetics.
It takes effect one year after official promulgation. (Personal Care Insights / CNS Media) - Key provisions: centralized authority under the Ministry of Health and Welfare,
“Innovative Cosmetics Company” certification, mandatory 5-year national plans,
and legal integration of AI and digital technology.
SMEs are the primary beneficiaries. - Korean cosmetics exports reached a record US$11.4 billion in 2025,
confirmed by the Ministry of Health and Welfare.
Quality control concerns have been flagged in secondary reporting;
specific figures require MFDS primary source verification. - Global market impact: state-backed R&D and export support
will likely strengthen Korean products’ competitiveness worldwide.
“Made in Korea” is not a regulatory approval —
always verify local regulatory status before clinical use.
Frequently Asked Questions
following State Council approval and formal publication.
As of August 2026, implementing regulations — including certification criteria — are still being drafted.
The law applies only within Korea.
However, indirect effects on global markets are expected
through increased export competitiveness of Korean products and technologies over the coming years.
Korean cosmetics sold in other markets have undergone separate regulatory review
under local frameworks (e.g., FDA, EMA, PMDA).
A Korean recall does not automatically trigger action in other markets.
However, if the same product is distributed internationally,
ingredient or safety concerns may warrant independent review.
Consumers can cross-reference product lot numbers and ingredient lists
to determine whether a recalled product matches what they are using.
skincare, makeup, and related consumer products.
Aesthetic medical procedures, injectable treatments, and medical devices
fall under separate regulatory frameworks and are not covered by this law.
That said, Korea’s technology export ambitions in adjacent categories
(such as HIFU devices and skin boosters) may benefit indirectly
from the broader national support infrastructure this law establishes.
“K-beauty” is often used loosely to encompass both cosmetics and aesthetic medicine,
but the legal scope here is limited to cosmetics.
Sources
- Personal Care Insights (CNS Media). “South Korea passes landmark law to fuel K-beauty industry.” by Sabine Waldeck. August 24, 2026. personalcareinsights.com
- Korea Ministry of Health and Welfare (보건복지부). Official announcement on the Cosmetics Industry Promotion and Support Act. August 2026.
- MFDS (Ministry of Food and Drug Safety / 식품의약품안전처). Cosmetics recall and safety monitoring data. (Primary source verification ongoing as of August 2026.)
